NIH-funded research R01 grant

Automated language analysis for Alzheimer’s disease and frontotemporal dementia in Latino and English speakers

Official title: An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populations

Funded at University of California, San Francisco · NIH-11553470 · Data updated 2026-11-12

A low-cost, automated speech and language analysis tool is being developed to help identify Alzheimer’s disease or frontotemporal dementia in Latino and English-speaking people.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 15, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$139,133
NIH project number3R01AG075775-04S5
Project IDNIH-11553470 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with or at risk for Alzheimer's disease or frontotemporal dementia, including Spanish-speaking and English-speaking adults across diverse backgrounds.

Less likely to help

People without cognitive impairment or with conditions outside AD/FTD are unlikely to benefit from this diagnostic tool.

What this research studies

This project creates a new, computer-based language analysis framework that uses speech data from diverse participants to detect and predict cognitive disruptions related to Alzheimer’s disease and frontotemporal dementia. It will collect natural speech samples and extract acoustic and linguistic features, then apply machine learning to separate disease signals from socio-biological factors like language, race, and bilingualism. The study plans to enroll about 2,740 participants, including Spanish and English speakers across multiple countries and the US, to ensure the approach works across diverse groups. By comparing with standard diagnostic measures, the work aims to produce a robust, scalable tool that remains valid across languages and dialects. The ultimate goal is to improve access to accurate diagnosis for Latino populations who face barriers to current testing.

Why it matters

Potential benefit: If successful, patients could receive earlier and more accessible diagnosis through a low-cost, language-adapted tool.

How similar studies have gone: Past work shows promise for language-based markers, but few studies have large, diverse Latino/English cohorts or cross-language validation; this project builds on emerging evidence with a broader, more inclusive approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Gorno Tempini, Maria Luisa — University of California, San Francisco
  • Study coordinator: Gorno Tempini, Maria Luisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.